Abstract:Objective To explore the correlation between the fractional exhaled nitric oxide (FeNO) and small airway function in adults with bronchial asthma at the first diagnosis and the effects of smoking and allergic rhinitis on FeNO.Methods According to the inclusion and exclusion criteria,a total of 42 adult asthma patients admitted to the Shanghai General Hospital from September 1,2016 to November 30,2016 were enrolled in this study.Their FeNO and eosinophil relative value (Eos％) count were measured.Meanwhile,the pulmonary function was detected,including the percentage of forced expiratory volume at 1 second (FEV1) in the predicted value (FEV1％) and maximum mid-expiratory flow (MMEF).The airway impedance value of frequency at 5 Hz and 20 Hz (R5-R20) was recorded by impulse oscillometry (IOS).Results FeNO was positively correlated with Eos％,MMEF and FEV1％ (r=0.433,P=0.004;r=0.399,P=0.009;r=0.315,P=0.043),but not significantly correlated with R5-R20 (P＞0.05);and there was a significantly negative correlation between MMEF and R5-R20 (r=0.501,P =0.001).In 16 patients combined with allergic rhinitis,there was a significantly positive correlation between FeNO and Eos％ (r =0.585,P =0.002),while no relationship was found between FeNO with FEV1％ or MMEF,R5-R20 (all P＞0.05).In 26 patients without allergic rhinitis,FeNO was positively correlated with FEV1 and MMEF (r=0.505,P=0.009;r=0.431,P=0.027),but not with Eos％ and R5-R20 (both P＞ 0.05).In 14 smoking asthmatic patients,FeNO was not correlated with other parameters of lung function or small airway function (all P＞0.05).But FeNO was positively correlated with Eos％,FEV1 and MMEF in 28 nonsmoking asthmatic patients (r=0.562,P=0.002;r=0.572,P=0.002;r=0.485,P=0.009),and no correlation between FeNO and R5-R20 in these patients (P＞0.05).A receiver operating characteristic (ROC) analysis showed that FeNO combines with MMEF had a greater area under the ROC curve (AUC=0.967,95 ％ CI =0.901-1.033,P =0.002) than MMEFonly (AUC=0.954,95％CI=0.866-1.042,P=0.003) and FeNO combined withR5-R20 (AUC=0.849,95％CI=0.691-1.007,P=0.022).Conclusion FeNO has acertain clinical value in assessing small airway dysfunction in asthmatic patients,and it is more valuable when combines with MMEF.In addition,FeNO may play a more important role in diagnosis of bronchial asthma in patients without smoking and allergic rhinitis.

Recent advances in asthma biomarker research

Small-Airway Function Variables in Spirometry, Fractional Exhaled Nitric Oxide, and Circulating Eosinophils Predicted Airway Hyperresponsiveness in Patients with Mild Asthma.

Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?

Biomarkers in asthma, potential for therapeutic intervention

Breath and Sputum Analyses in Asthmatic Patients: An Overview

Clinical utility of asthma biomarkers: from bench to bedside

The Value of Fractional Exhaled Nitric Oxide and Forced Mid-Expiratory Flow As Predictive Markers of Bronchial Hyperresponsiveness in Adults with Chronic Cough.

Utility of biomarkers in the diagnosis and monitoring of asthmatic children

Improving the diagnosis of eosinophilic asthma

Critical evaluation of asthma biomarkers in clinical practice

Correlation between fractional exhaled nitric oxide and small airway function in patients with bronchial asthma and its influencing factors

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma

Biologics in Asthma: Role of Biomarkers

Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD

Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis

Recent developments and highlights in biomarkers in allergic diseases and asthma

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation

Biomarkers in asthma: state of the art

Noninvasive Markers of Airway Inflammation in Asthma

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma